Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hoth Therapeutics

0.8990
+0.04805.64%
Volume:121.11K
Turnover:105.01K
Market Cap:11.84M
PE:-0.70
High:0.9100
Open:0.8500
Low:0.8267
Close:0.8510
Loading ...

BRIEF-Hoth Therapeutics Partners With Ontargetx Research And Development

Reuters
·
10 Feb

Hoth Therapeutics announces collaboration with OnTargetx R&D

TIPRANKS
·
10 Feb

Hoth Therapeutics Partners With Ontargetx R&D to Advance Research for Cancer Fighting Ht-Kit Cancer Therapeutic

THOMSON REUTERS
·
10 Feb

Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic

PR Newswire
·
10 Feb

Corrected-Hoth Therapeutics Shares Down 5% at $1.10 in Extended Trade Following Filing for Stock Offering (Deletes Erroneous Reference to Share Gain)

THOMSON REUTERS
·
08 Feb

BRIEF-Hoth Therapeutics Files For Common Stock Offering Of Up To $5 Million

Reuters
·
08 Feb

Hoth Therapeutics: Files for Common Stock Offering of up to $5 Mln - SEC Filing

THOMSON REUTERS
·
08 Feb

Hoth Therapeutics Regains Compliance With Nasdaq Listing Rule

MT Newswires Live
·
24 Jan

BRIEF-Hoth Therapeutics Regains Compliance With Nasdaq Listing Requirements

Reuters
·
24 Jan

Hoth Therapeutics regains compliance with Nasdaq listing rules

TIPRANKS
·
24 Jan

Hoth Therapeutics Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
24 Jan

Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements

PR Newswire
·
24 Jan

Hoth Therapeutics Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
23 Jan

H.C. Wainwright Reaffirms Their Buy Rating on Hoth Therapeutics (HOTH)

TIPRANKS
·
23 Jan

Hoth Therapeutics Expands Intellectual Property Portfolio With Acquisition of New Patent Applications

THOMSON REUTERS
·
21 Jan

Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications

PR Newswire
·
21 Jan

Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

PR Newswire
·
17 Jan

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks
·
10 Jan

Hoth Therapeutics Shares Recover; Company Has No Plans for Offering

Dow Jones
·
09 Jan

Hoth Therapeutics Affirms No Plan to Raise Fresh Capital

MT Newswires Live
·
09 Jan